A primary goal of the ARLG is to train the next generation of researchers who will help reduce the public health threat of antibacterial resistance.
LEARN MORE
The latest ARLG Network newsletter is now available, featuring new research highlights, member and clinical trial site spotlights, upcoming events, study milestones, and recent publications from across the ARLG community.
In this issue, readers can learn more about ARLG Co-Principal Investigator Vance Fowler, MD, MHS, receiving ISAC’s highest honor; recent ARLG research featured in JAMA and Open Forum Infectious Diseases; and more.
The June 2026 newsletter features the new ARLG Innovative Research Tools and Methods page, network news including two ARLG studies featured in a late-breaking session at ESCMID, and a clinical trial site spotlight on the University of Alabama at Birmingham. The newsletter also includes ARLG member spotlights, recent publications, study milestones, and more.
The March 2026 newsletter features updates on ARLG studies, new publications, and a clinical trial site spotlight on Mayo Clinic. The newsletter also includes two new member spotlights on Heather Cross, Director of the ARLG Clinical Operations Center and Associate Director of the ARLG Scientific Leadership Center, and Robin Patel, Director of the ARLG Laboratory Center.
The December 2025 newsletter features updates on the PHAGE and DOTS (Dalbavancin as an an Option for Treatment of Staphylococcus aureus bacteremia) studies as well as a clinical trial site spotlight on the University of North Carolina. The newsletter also includes a mentee spotlight, study milestones, recent publications, and more ARLG network news.
The September 2025 newsletter highlights the new ARLG supplement published in the journal of Clinical Infectious Diseases and celebrates the important work of recent retirees who dedicated years of service to the ARLG. This edition of the newsletter also includes a new clinical site spotlight, study milestones, recent publications, and more.
The July 2025 newsletter introduces our new Spotlight on Clinical Sites and highlights many ways the ARLG is working to combat the antibacterial resistance crisis and improve patient care. This edition of the newsletter also includes ARLG member and mentee spotlights, study milestones, new publications, and more.
The January 2025 newsletter features exciting highlights, study milestones, new publications, member spotlights, and more!
The October 2024 newsletter features exciting highlights from IDWeek 2024, including Dr. Roach winning Innovator of the Year at the IDea Incubator competition, Drs. Tamma and Hanson receiving awards for their contributions to the field of infectious diseases, and Dr. Bonomo delivering the Maxwell Finland Lecture. Read on for exciting study milestones, new publications, member spotlights, and more!
The July 2024 newsletter features an interview with GENO-STELLARTM Principal Investigator, Blake Hanson, PhD, A recap of ARLG presentations and posters at ESCMID Global 2024, exciting study milestones, new publications, member spotlights, and more!
The April 2024 newsletter features the announcement of a global partnership formed to combat antibacterial resistance, a new appointment for ARLG member Eli Perencevich, MD, MS, exciting GENO-STELLARTM news, ARLG posters and sessions at ECCMID 2024, member spotlights, and more!